Dr. Skoumbourdis serves as Context's Sr. Director, Program Management. She brings over 20 years of combined experience in discovery and translational research and integrated program management in biotech and pharma and has held project management roles of increasing responsibility for over 10 years. Prior to joining the Company, Dr. Skoumbourdis was Head of Project Management at Code Bio, where she led PMO and operational activities. She has held program management positions with Spark Therapeutics and Gyroscope Therapeutics, where she led IND-enabling studies for the company's second asset and was the business partner to the SVP of Technical Operations, supporting device development and alliance management for the manufacturing team. Dr. Skoumbourdis began her pharmaceutical career at Sandoz, Inc. a Novartis Company, where she served as the first scientific advisor for the intellectual property group.

Dr. Skoumbourdis earned a Bachelor of Science in Chemistry from The College of New Jersey and PhD in Synthetic Organic Chemistry from Pennsylvania State University. She was awarded an IRTA Postdoctoral Fellowship at The National Institutes of Health in Bioorganic and Medicinal Chemistry. 

Erin Zebrowski is the Senior Director of Quality at Context Therapeutics. She is responsible for all aspects of GMP/GCP/GLP quality for the organization. Erin has more than 15 years’ experience in the pharmaceutical industry in various analytical and quality assurance roles. Prior to joining Context, she has held various technical positions at Becton Dickinson, UPM Pharmaceuticals, Nutramax Laboratories, Eisai Inc., Epicur Pharma, and TG Therapeutics.

Erin holds a BS degree in Chemistry from York College of Pennsylvania and an MPS in Biotechnology (Regulatory Track) from University of Maryland Baltimore County.